Overview

ATEM (Alvesco Non-interventional Study)

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the efficacy of Alvesco in patients with persistent asthma including or excluding allergic components over 3 months, especially in the spring season. Alvesco will be inhaled by a metered-dose inhaler. The study will provide further data on safety and tolerability of Alvesco .
Details
Lead Sponsor:
AstraZeneca
Treatments:
Ciclesonide